Amicus Therapeutics, Inc. (FOLD) Investor Investigation over Potential Wrongdoing

San Diego, CA -- (SBWIRE) -- 12/06/2016 -- An investigation on behalf of investors in NASDAQ:FOLD shares was announced over potential breaches of fiduciary duties by certain directors at Amicus Therapeutics.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.